did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780521796897

Bacterial Disease Mechanisms: An Introduction to Cellular Microbiology

by
  • ISBN13:

    9780521796897

  • ISBN10:

    052179689X

  • Format: Paperback
  • Copyright: 2002-05-13
  • Publisher: Cambridge University Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $120.00 Save up to $36.00
  • Rent Book $84.00
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    SPECIAL ORDER: 1-2 WEEKS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Antibiotic resistance and our consequent inability to treat many bacterial infections had fuelled an urgent need to understand the means by which bacteria cause disease. This has lead to a renaissance in research into bacterial disease mechanisms and the birth of a new discipline - cellular microbiology. The fruits of such research and how they have lead to an alternative perspective on bacteria-host interactions are described in this introductory textbook. The central premise is that bacteria have evolved means of manipulating normal host cell functions and overcoming host defence systems to ensure their survival. As well as offering an interesting perspective on the classical bacterial virulence mechanisms, this book outlines the molecular techniques developed to unravel the complexity of bacteria-host interactions. Research may lead not only to a better understanding of disease mechanisms, but also to alternative means of preventing and/or treating bacterial infections.

Table of Contents

Preface xvii
Abbreviations used xxi
An introduction to bacterial diseases
1(45)
Introduction
1(1)
The normal bacterial flora of humans
2(14)
The skin
7(2)
The oral cavity
9(1)
The respiratory tract
10(2)
The gastrointestinal tract
12(3)
The urogenital tract
15(1)
Bacteria and disease
16(10)
Types of host-bacteria interaction
16(2)
Diseases caused by members of the normal microflora
18(2)
Damage to the epithelium
20(1)
The presence of a foreign body
21(1)
The transfer of bacteria to sites where they are not part of the normal microflora
21(1)
Suppression of the immune system by drugs or radiation
22(1)
Impairment of host defences due to infection by an exogenous pathogen
22(1)
Disruption of the normal microflora by antibiotics
23(1)
Unknown precipitating factor
23(1)
Exogenous infections
24(2)
The spectrum of bacterial diseases
26(10)
Infections that are not usually accompanied by tissue invasion and Dissemination
28(1)
Infections confined to mucosal surfaces
28(3)
Infections confined to the skin
31(2)
Infections accompanied by tissue invasion and dissemination
33(1)
Causative organism produces an exotoxin
33(1)
Causative organism does not produce an exotoxin
34(2)
Concept check
36(1)
Introduction to the paradigm organisms
37(3)
Streptococcus pyogenes
37(2)
Escherichia coli
39(1)
What's next?
40(1)
Questions
41(1)
Further reading
42(2)
Internet links
44(2)
Bacterial cell biology
46(65)
Introduction
46(1)
Bacterial ultra structure
47(10)
Size, shape and organisation
47(2)
Cytoplasmic membrane
49(1)
Cytoplasm
50(1)
Bacterial cell wall
50(1)
Gram-positive cell wall
51(2)
Gram-negative cell wall
53(1)
Cell wall of Mycobacterium spp.
54(1)
Surface appendages
55(1)
Cell-surface-associated components
56(1)
Bacterial cell cycle
57(2)
Sporulation
59(2)
Bacterial protein secretion systems
61(14)
The general secretory pathway
62(2)
The Tat export pathway
64(2)
Terminal branches of the GSP
66(1)
The main terminal branch (type II secretion)
67(2)
The chaperone-usher pathway
69(1)
Type IV secretion
69(1)
Type I secretion
70(2)
Type III secretion
72(3)
Genetic aspects of bacterial virulence
75(21)
Gene regulation
76(1)
Sensing changes in the environment
76(1)
Gene transcription
77(2)
Gene induction and repression
79(3)
Antigenic and phase variation
82(1)
DNA inversion
82(2)
DNA recombination
84(1)
Slipped-strand mispairing
85(1)
Epigenetic variation
86(1)
Point mutations
86(1)
Mobile genetic elements
87(1)
Plasmids
87(1)
Bacteriophages
88(1)
Transposable elements
89(3)
Pathogenicity islands
92(4)
Bacterial biofilms
96(5)
Concept check
101(1)
Cell biology of the paradigm organisms
102(4)
Streptococcus pyogenes
102(3)
Escherichia coli
105(1)
What's next?
106(1)
Questions
106(1)
Further reading
107(2)
Internet links
109(2)
Molecular analysis of bacterial virulence mechanisms
111(51)
Introduction
111(2)
Mutational analysis
113(8)
Directed mutagenesis
113(3)
Random mutagenesis
116(1)
Signature-tagged mutagenesis
117(4)
Protein expression approaches
121(9)
Surface and secreted proteins
121(3)
Proteomics
124(1)
Proteomic methodology
124(5)
Proteomics in microbiology
129(1)
Subtractive and differential analysis of mRNA
130(4)
In vivo expression technology
134(3)
Reporter systems
137(4)
Genomic approaches
141(3)
Assessing gene expression using DNA microarrays
144(2)
Eukaryotic molecular methods
146(11)
Yeast two-hybrid screening
146(1)
Description of the technique
146(2)
Use of the two-hybrid system in investigating bacterial virulence factors
148(1)
Transgenesis and the generation of gene knockouts
149(1)
Description of the technique
149(2)
Knockout mice in bacterial virulence research
151(2)
Dominant-negative mutants
153(1)
Description of the technique
153(2)
Use of dominant-negative mutants in the study of bacterial virulence
155(1)
Oligonucleotide-based gene inactivation
156(1)
Concept check
157(1)
What's next?
157(1)
Questions
158(1)
Further reading
158(3)
Internet links
161(1)
Communication in infection
162(76)
Introduction
162(2)
Eukaryotic cell signalling
164(45)
A brief overview of eukaryotic cell-cell signalling
164(1)
Cell receptors for signal transduction
165(1)
Ion channel receptors
166(1)
G protein-coupled receptors (GPCR)
166(3)
The GTPase superfamily
169(1)
Receptors with inherent enzymic activity
170(2)
Receptors linked to a separate cytoplasmic enzyme
172(1)
Intracellular signal transduction
172(2)
The basic building blocks of intracellular signal transduction
174(8)
Signal transduction and selective gene transcription
182(1)
The JAK/STAT pathway of gene activation
183(1)
Gene transcription via the MAP kinase pathways
184(4)
Signal transduction and the cell cytoskeleton
188(1)
Integrins and cell signalling
189(1)
Small GTPases and regulation of the actin cytoskeleton
189(3)
Cyokines: key host signalling molecules
192(1)
A brief history of cytokines
193(1)
Properties of cytokines
194(1)
Cytokine nomenclature
195(1)
Biological actions of cytokines
195(5)
Cytokine networks
200(1)
Cytokine structure and cytokine receptors
201(8)
Prokaryotic cell signalling
209(16)
Intracellular signalling in prokaryotes
209(1)
Introduction
209(2)
Two-component signal transduction
211(5)
Other signal transduction pathways in bacteria
216(1)
Monitoring of the internal environment of the bacterium
216(1)
Cell-cell signalling in bacteria
216(1)
Quorum sensing
216(8)
Bacterial cytokines
224(1)
Bacterial reception of host signals
225(3)
Concept check
228(1)
Signalling in the paradigm organisms
229(3)
Streptococcus pyogenes
229(1)
Intracellular signalling
229(1)
Intercellular signalling
229(1)
Host-bacteria signalling
230(1)
Escherichia coli
230(1)
Intracellular signalling
230(1)
Intercellular signalling
231(1)
Host-bacteria signalling
231(1)
What's next?
232(1)
Questions
232(1)
Further reading
233(3)
Internet links
236(2)
The mucosal surface: the front line of antibacterial defence
238(40)
Introduction
239(1)
An overview of antibacterial defence
239(2)
The mucosal surface
241(5)
Epithelial cells and epithelia
242(4)
Mucosal antibacterial defences
246(14)
The mucosal surface as a physical barrier to bacteria
246(2)
Antibacterial chemicals produced by the mucosae
248(1)
Antibacterial biomolecules produced by the mucosae
248(1)
Mucin
249(1)
Lysozyme
249(2)
Lactoferrin
251(1)
Lactoperoxidase
252(1)
Secretory phospholipase A2
253(1)
Secretory leukocyte protease inhibitor
253(1)
Trefoil peptides
253(1)
Acute phase proteins
254(1)
Collectins
254(1)
Secretory IgA
254(1)
Antibacterial peptides
255(5)
Overview of the synthesis of antibacterials by mucosal epithelial cells
260(1)
The mucosal epithelium as a shedding surface
260(3)
The normal microflora as an antibacterial agent
263(3)
Other cell populations in mucosal epithelia
266(3)
M cells
266(2)
Paneth cells
268(1)
Intra-epithelial lymphocytes
269(1)
The mucosal epithelium as a watchdog
269(2)
Concept check
271(1)
The paradigm organisms and mucosal surfaces
272(3)
Streptococcus pyogenes
272(1)
Escherichia coli
273(2)
What's next?
275(1)
Questions
275(1)
Further reading
275(2)
Internet links
277(1)
Immune defences against bacteria
278(75)
Introduction
279(1)
How would you design an immune system to defend yourself against bacteria?
280(2)
The cell populations involved in immunity to bacteria
282(12)
Monocytes, macrophages, dendritic cells
283(2)
Granulocytes
285(2)
Mast cells and basophils
287(1)
Lymphocytes
288(4)
M cells
292(1)
Vascular endothelial cells
292(2)
The soluble effector molecules of inflammation and immunity
294(4)
Acute phase proteins
294(1)
Complement system
295(1)
Antibodies
296(1)
Cytokines
297(1)
Organization of the immune system
298(5)
Innate immunity
303(18)
How do you recognise a pathogen?
304(1)
Pattern recognition receptors
304(3)
Drosophila, Toll, Toll-like receptors and the Ips locus
307(1)
Complement: a recognition and effector system of antibacterial defence
308(6)
Phagocytes and phagocytosis of bacteria
314(1)
Receptors involved in phagocytosis
314(4)
Phagosomes, vesicular transport and generation of the phagolysosome
318(1)
Bacterial killing in the phagolysosome
319(2)
Acquired immunity
321(23)
Generation of diversity (GOD)
323(1)
Major histocompatibility complex proteins and antigen presentation
324(1)
MHC proteins
324(2)
An introduction to antigen presentation
326(11)
Functions of effector T cell populations
337(3)
CD4 effector mechanisms: Th1 and Th2 lymphocytes
340(1)
The Th1/Th2 paradigm
340(1)
Generation of Th1 and Th2 lymphocytes
341(1)
Effector functions of Th1 lymphocytes
342(2)
A brief overview of the immune response to bacterial infections
344(3)
Concept check
347(1)
Immune defences and the paradigm organisms
347(2)
Streptococcus pyogenes
347(1)
Escherichia coli
348(1)
What's next?
349(1)
Questions
349(1)
Further reading
350(1)
Internet links
351(2)
Bacterial adhesion as a virulence mechanism
353(52)
Introduction
353(2)
To what do bacteria adhere?
355(5)
Adhesion to external body surfaces
355(2)
Adhesion to internal surfaces
357(1)
Adhesion under the microscope - to what do bacteria really adhere?
358(2)
Mechanisms involved in bacterial adhesion
360(13)
Pre-adhesion events
360(2)
Adhesive interactions
362(1)
Hydrophobic interactions
362(1)
Cation-bridging
363(1)
Receptor-ligand binding
363(1)
Bacterial structures involved in adhesion
364(1)
What bacterial structures are involved in adhesion?
364(3)
What is the nature of the adhesins on the structures involved in adhesion?
367(3)
Host molecules functioning as receptors
370(3)
Tissue tropism
373(2)
Consequences of bacterial adhesion
375(18)
Effects on the bacterium
376(1)
Effects on the host
377(1)
Epithelial cells
377(12)
Fibroblasts
389(1)
Endothelial cells
390(2)
Phagocytic cells
392(1)
Prevention of bacterial adhesion
393(2)
Concept check
395(1)
Adhesion of the paradigm organisms
395(4)
Strcptococcus pyogenes
395(4)
Escherichia coli
399(1)
What's Next?
399(1)
Questions
400(1)
Further reading
401(3)
Internet links
404(1)
Bacterial invasion as a virulence mechanism
405(61)
Introduction
405(4)
Invasion mechanisms
409(32)
Invasion of epithelial cells
412(1)
Invasion involving actin rearrangements
413(19)
Invasion involving microtubules
432(1)
Paracytosis
433(2)
Invasion of vascular endothelial cells
435(1)
Neisseria meningitidis
435(1)
Listeria monocytogenes
436(1)
Citrobacter freundii
437(1)
Bartonella henselae
437(1)
β-Haemolytic streptococci
437(1)
Streptococcus pneumoniae
437(4)
Consequences of invasion
441(6)
Effects on host cells
441(1)
Cytokine release
442(1)
Prostaglandin release
443(1)
Effects on the expression of adhesion molecules and neutrophil adhesion
443(1)
Cell death
444(1)
Synthesis of tissue factor
444(2)
Effects on bacteria
446(1)
Bacterial survival and growth subsequent to invasion
447(9)
Intracellular lifestyle
448(1)
Survival within vacuoles
448(4)
Survival in the cytoplasm of the host cell
452(3)
Extracellular lifestyle
455(1)
Concept check
456(1)
Invasion of host cells by the paradigm organisms
456(5)
Streptococcus pyogenes
456(2)
Escherichia coli
458(3)
What's next?
461(1)
Questions
461(1)
Further reading
462(3)
Internet links
465(1)
Bacterial exotoxins
466(48)
Introduction
466(1)
Classification of toxins by their activity
467(1)
Type I (membrane-acting) toxins
468(5)
Stable toxin (ST) family
469(3)
Bacterial superantigens
472(1)
Type II (membrane-damaging) toxins
473(14)
Channel-forming toxins
473(1)
Channel formation involving β-sheet-containing toxins
473(4)
Channel formation involving α-helix-containing toxins
477(1)
`Thiol-activated' cholesterol-binding cytolysins
478(5)
RTX toxins
483(4)
Toxins that damage membranes enzymically
487(1)
Phospholipases
487(1)
Proteases
487(1)
Type III (intracellular) toxins
487(18)
AB5 toxins
489(1)
The cholera toxin paradigm
489(3)
Same, organization, different function: Shiga toxins are N-glycosidases
492(4)
ADP-ribosylation is a common toxin activity
496(1)
Pertussis toxin, a variant AB5 design
496(1)
ADP-ribosyltransferases of Pseudomonas aeruginosa
497(1)
Binary ADP-ribosylating toxins
498(1)
Other AB toxin activities
498(1)
Glucosyltransferase
498(1)
Deamidase
499(1)
Protease
500(1)
Adenylyl cyclase
501(1)
Type III secretion and toxin 'injection'
502(1)
Yersinia spp.
503(1)
Pseudomonas aeruginosa
503(1)
Type IV secretion and toxin `injection'
504(1)
Toxins as therapeutic agents
505(2)
Vaccines
505(1)
Mucosal vaccines
505(1)
Chimeric Immunotoxins
506(1)
Muscle spasms
507(1)
Concept check
507(1)
Toxins produced by the paradigm organisms
507(3)
Streptococcus pyogenes
507(2)
Escherichia coli
509(1)
What's next?
510(1)
Questions
511(1)
Further reading
511(2)
Internet links
513(1)
Bacterial evasion of host defence mechanisms
514(69)
Introduction
514(2)
Evasion of immune defences at mucosal Surfaces
516(4)
Evasion of secretory IgA
516(3)
Evasion of antibacterial peptides
519(1)
Cytokines in antibacterial defence: mechanisms of microbial evasion
520(12)
Modulins
522(2)
Virokines and viroceptors
524(1)
Virokines
525(2)
Viroceptors
527(1)
Cytokine transcription
527(1)
Bacterial evasion of cytokines
527(5)
Evasion of innate immune mechanisms
532(16)
Complement evasion
532(1)
Bacterial capsules
533(1)
Proteases and complement evasion
533(1)
Interference with complement regulatory proteins
534(3)
Evasion of phagocytic killing
537(1)
Evasion of killing by means of type III secretion systems
538(2)
Intracellular parasitism: a novel mechanism to evade phagocytosis
540(7)
Evasion of antigen processing
547(1)
Evasion of acquired immunity
548(10)
Evasion of antibodies
550(1)
Bacterial immunoglobulin-binding proteins
550(1)
Antigenic variation
551(3)
Superantigens and evasion of T lymphocyte responses
554(4)
Bacterial control of the cell cycle and apoptosis as evasion mechanisms
558(17)
Bacterial inhibition of cell cycle progression
558(1)
The eukaryotic cell cycle
558(1)
Bacterial proteins with the ability to control cell cycle progression
559(4)
Bacterial control of apoptosis
563(1)
The mechanism of apoptosis
564(5)
Bacterial control of the apoptotic process
569(6)
Concept check
575(1)
Evasion of host defences by the paradigm organisms
575(3)
Streptococcus pyogenes
575(1)
Escherichia coli
576(2)
What's next?
578(1)
Questions
578(1)
Further reading
578(4)
Internet links
582(1)
Bacteria in human health and disease: the future?
583(32)
Introduction
583(2)
Identification of bacterial virulence genes and virulence mechanisms in vivo
585(4)
Caenorhabditis elegans and bacterial virulence
586(1)
Study of bacterial pathogenic mechanisms in humans
587(2)
Development of new antibacterials
589(5)
Inhibition of bacterial adhesion
590(2)
Antibacterial peptides
592(1)
Antisense
592(1)
Other approaches
592(1)
New targets from genomics
593(1)
Using genomics to identify vaccine candidates
594(1)
Genomics to identify the basics of life
594(1)
Bacteria and idiopathic diseases
595(9)
Helicobacter pylori, ulcers and cancer
597(1)
Bacteria and heart disease
598(4)
Other diseases possibly caused by bacteria
602(1)
Psoriasis
602(1)
Kidney stones
602(1)
Asthma and the hygiene hypothesis
603(1)
Conversations with the normal microflora
604(7)
Vibrio fischeri and the bobtail squid
604(3)
The mammalian intestine: another host-microbe interface
607(1)
Alterations in intestinal anatomy/renewal in gnotobiotic mice
607(2)
Alterations in the GALT of gnotobiotic mice
609(1)
Alteration in epithelial cell differentiation in gnotobiotic mice
609(2)
Wolbachia pipientis and insect reproduction
611(1)
Summary
611(1)
Further reading
612(2)
Internet links
614(1)
Appendix A. Glossary of terms used 615(18)
Appendix B. Brief descriptions of bacteria frequently mentioned 633(6)
Index 639

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program